Baker McKenzie Baker McKenzie
How Can We Help?
Language:
English
Photo of Tracy Wut

Tracy Wut

Partner
Baker & McKenzie

Biography

Tracy Wut is experienced in mergers and acquisitions and foreign direct investments in China. She regularly acts for clients in complex cross-border transactions, in particular in the pharmaceuticals and healthcare sector, and navigates clients through various issues relating to investments in China. She has been recommended as a leading lawyer in Corporate/M&A by Chambers Global, Corporate/M&A and Life Sciences by Chambers Asia and M&A and private equity by IFLR1000. She is the co-head of the Pharmaceuticals and Healthcare Industry Group in China and Hong Kong.

Practice Focus

Tracy is knowledgeable in mergers and acquisitions, as well as a broad range of corporate and commercial matters relating to investment in China.

Representative Legal Matters

  • Advised Gaw Capital Partners and a consortium of institutional investors, including Schroder Pamfleet, on the HKD 9.845 billion acquisition of CityPlaza One office building from Swire Pacific and Swire Properties. This transaction was named “M&A Deal of the Year” in the ALB Hong Kong Law Awards 2021.

  • Acted for Cardinal Health in its acquisition of Zuellig Pharma’s China business.

  • Acted for Nycomed in its acquisition of a majority stake in Guangzhou Techpool Biopharma.

  • Acted for Itochu Corporation in its strategic investment in Citic International Assets Management Ltd.

  • Acted for Brown Shoe in the international aspects of its acquisition of American Sporting Goods.

  • Acted for OSRAM in the joint venture with Traxon Technologies, a leading global LED lighting provider.

  • Acted for Fortis Investments/ABN Amro in its sale of a 49 percent stake in a PRC fund management company.

  • Acted for Beiersdorf in the acquisition of C-BONS’ hair care business in China.

  • Acted for Calyon Financial Hong Kong Ltd. on its acquisition of a stake in CITIC Futures Co. Ltd.

Professional Honors

  • Leading Lawyer (Corporate/M&A: Hong Kong-based (International Firms), China/Hong Kong), Chambers Greater China Region, 2022 
  • Leading Lawyer (Corporate/M&A: Hong Kong), Legal 500 Asia Pacific, 2020-2022
  • Leading Lawyer (M&A, Hong Kong), IFLR1000, 2012-2022
  • Leading Lawyer (Private Equity, Hong Kong), IFLR1000, 2011 & 2015-2022
  • Leading Lawyer (Corporate/M&A: Hong Kong-based (International Firms), China/Hong Kong), Chambers Asia Pacific, 2009-2021 
  • Leading Lawyer (Corporate/M&A: Hong Kong-based (International Firms), China/Hong Kong), Chambers Global, 2010-2012, 2014-2020
  • Leading Lawyer (Corporate/M&A: High-end Capability: Hong Kong-based (International Firms), China/Hong Kong), Chambers Global, 2013
  • Leading Lawyer (Life Sciences (International Firms), China/Hong Kong), Chambers Asia Pacific, 2013-2019 
  • Recommended Lawyer (Life Sciences: corporate & commercial, China and Hong Kong), PLC Which Lawyer?, 2012

Professional Associations and Memberships

  • Law Society of Hong Kong

Admissions

  • England & Wales (non-practicing) (1998)
  • Hong Kong (1997)

Education

  • The University of Hong Kong (P.C.LL.) (1995)
  • The University of Hong Kong (LL.B.) (1994)

Languages

  • Cantonese
  • English
  • Mandarin
Baker & McKenzie, a Hong Kong partnership, is a member of Baker & McKenzie International, a Swiss Verein.
We use cookies to improve your experience on our website. To find out more about the cookies we use and how to change your settings if you do not want cookies to be placed on your device, please read our Privacy and Cookies Statement.
Accept